A Spanish cancer test, among the best inventions of 2022 for ‘TIME’ magazine

the American magazine Time he acknowledged HER2DX extensionAnd genomic proof developed in Spain and indicating the best treatment for breast cancer patientshow one of the 13 best inventions of 2022 in the healthcare category, as the publication believes these findings “make the world better, smarter, and even more fun.”

This test was created by to boot biotechnological Reveal genomics, specializing in precision oncology through innovation in biomarkers. Behind it is the support of the Hospital Clínic, the University of Barcelona, ​​​​the Idibaps institute and the Vall d’Hebron Institute of Oncology (VHIO).

El try HER2DX combine clinical data such as tumor size or lymph node status, which have traditionally guided treatment decisions, with data on the activity of the 27 geneswhich are the ones that indicate how the cancer cells and how is the environment of the tumor. To process the large number of variables that come into play deep learning techniques were useda branch of the artificial intelligence.

A more appropriate treatment

This proof is indicated for women with HER2+ cancerrepresenting 20% of all cases of breast cancer, i.e. about 400,000. Magazine Time pointed out that the HER2DX extension “helps achieve better outcomes for early stage patients of the disease, but also could lead to more personalized therapies for breast cancers advanced stage“.

Until date, no tools were available to assist the oncologist in prescribing the most appropriate therapeutic treatment for every patient with this heterogeneous type of cancer, many have experienced it over or under treatment. Now, with HER2DX, treatment is optimized for this type of patient.

Reveal genomics The test should be recommended in clinical practice guidelines in Europe and the United States once it has proven its usefulness in a study expected to end in 2024. From then on, they will make it available worldwide so that it reaches all patients with HER2+ breast cancer. the HER2DX It is available from this year in Spainalthough for now it is not covered by the public health.

HER2DX is available in Spain, although it is not currently covered by public health

Time it does not establish a ranking of the 13 selected inventions, but gives them the same prominence. Between other scientific advances are found i vaccine against Nova Nordisk monkeypox, drugs Evusheld and Paxlovid against him covid or one tests for early detection of different types of cancer in the blood.

the American magazine Time he acknowledged HER2DX extensionAnd genomic proof developed in Spain and indicating the best treatment for breast cancer patientshow one of the 13 best inventions of 2022 in the healthcare category, as the publication believes these findings “make the world better, smarter, and even more fun.”